Author

Nilika Bhattacharya

Observed name: Bhattacharya, Nilika

Institution: Mayo Clinic in Arizona

Observed institution: Mayo Clinic in Arizona

OpenAlex ID: A5111323573

Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer

2024 · Casey R. Ager, Aleksandar Obradovic, et al. · medRxiv · 7

Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial

2026 · Casey R. Ager, Aleksandar Obradovic, et al. · Cell Reports Medicine · 4

OMIP‐118 : A 38‐Marker Spectral Flow Cytometry Panel to Assess Human Regulatory T Cell Phenotype and Lineage Plasticity

2025 · Nilika Bhattacharya, Collin Jugler, et al. · Cytometry Part A · 2

Abstract 166: Rewiring the dendritic cell: Regulatory T cell axis sensitizes prostate cancer to immunotherapy.

2026 · Jessica C. Hill, Kade R. Copple, et al. · Cancer Research

Fc-enhanced anti-CTLA-4 targets tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer

2026 · Obradovic, Aleksandar, Ager, Casey, et al. · Mendeley Data

Works count: 5

Citation count: 13

H-index: 2

I10-index: